MAPK8 and hepatocellular carcinoma: Several studies demonstrated that the downstream PI3K/Akt, ERK, and JNK signaling pathways of EGFR were activated in cancer metastasis of HCC, and the inhibition of EGFR or its downstream signal pathway would inhibit cancer metastasis [28, 30, 33].